)0|D6~{<_]'@5JOOZ{}[)55[}W
SYSTEM PROCESSING...
)0|D6~{<_]'@5JOOZ{}[)55[}W
SYSTEM PROCESSING...
Posted: 2025-04-24 04:54:27 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 04:56:21 UTC
Verified By
Rollup News
A research article published in the European Heart Journal (EHJ) suggests that expanding the triglyceride range in clinical trials may reveal novel therapeutic opportunities for dyslipidemia and hypertriglyceridemia.
Expanding the triglyceride range in clinical trials may reveal novel therapeutic opportunities.
Elevated triglycerides across the full range were associated with increasing cardiovascular risk.
Individuals with mild-to-moderate hypertriglyceridemia do not seem to express the same magnitude of cardiovascular risk from lowest to highest levels as that associated to higher levels of triglycerides.
Triglyceride-lowering therapy does not convincingly lower cardiovascular risk in individuals with mild-to-moderate hypertriglyceridemia.
Whether triglyceride levels predict cardiovascular risk beyond the constrained range.